PHENOTYPIC AND METABOLIC FEATURES OF CD4 AND CD8 T CELLS OF AN ELITE CONTROLLER
A CASE REPORT
DOI:
https://doi.org/10.58395/en47mb37Keywords:
HIV, ART, elite controllers, mitochondrial mass, mitochondrial membrane potentialAbstract
Background: People living with HIV (PLHIV) who are capable of long-term viral suppression in the absence of antiretroviral therapy (ART) are defined as elite controllers (EC). Although there is evidence of phenotypic and functional alterations of T-lymphocytes in EC, neither the mechanisms of viral control, nor the necessity and timing of ART in this particular population have been elucidated.
Case presentation: We report the case of untreated HIV+ patient with undetectable viral load (VL), and preserved CD4 T cell absolute count (AC) and CD4/CD8 ratio since diagnosis in 2018. The detailed phenotype of EC CD4 and CD8 T cell pools including differentiation, effector, activation, immunosenescence and exhaustion markers was distinct from sex- and age-matched ART+PLHIV with immune recovery, and close to HIV(-) healthy controls (HC), except for a temporary increase of CD57+ CD8 T cells in 2023. The only changing biomarkers were T cell mitochondrial mass (MM), slightly increased at the level of CD8 T cells in 2023, and drastically increased in both CD4 and CD8 T in 2025, together with the mitochondrial membrane potential (MMP), as compared to ART+PLHIV and HIV (-) HC.
Conclusions: CD4 and CD8 T cells of EC experience intensive oxidative stress and functional burden, possibly linked to the continuous effective HIV-specific immune response. CD4 and CD8 T cell MM may serve as a monitoring marker preceding the irreversible changes of immune profile and loss of viral control, and possibly predict the time for start of ART.
Downloads
References
1. Vidya Vijayan, K.K., et al., Pathophysiology of CD4+ T‑Cell Depletion in HIV-1 and HIV-2 Infections. Front Immunol, 2017. 8:p.580 https://doi.org/10.3389/fimmu.2017.00580
2. Bekker, L.G., et al., HIV infection. Nat Rev Dis Primers, 2023. 9(1): p. 42 https://doi.org/10.1038/s41572-023-00452-3
3. Navarrete-Munoz, M.A., et al., Elite controllers: A heterogeneous group of HIV-infected patients. Virulence, 2020. 11(1): 7p. 889-897 https://doi.org/10.1080/21505594.2020.178888
4. Deeks, S.G. and B.D. Walker, Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity, 2007. 27(3): p. 406-16 https://doi.org/10.1016/j.immuni.2007.08.010
5. Okulicz, J.F. and O. Lambotte, Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS, 2011. 6(3): p. 163-8 https://doi.org/10.1097/COH.0b013e328344f35e
6. Grabar, S., et al., Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS, 2009. 23(9): p. 1163-9 https://doi.org/10.1097/QAD.0b013e32832b44c8
7. Genovese, L., M. Nebuloni, and M. Alfano, Cell‑Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. Front Immunol, 2013. 4: p. 86 https://doi.org/10.3389/fimmu.2013.00086
8. Climent, N., et al., Immunological and virological findings in a patient with exceptional post-treatment control: a case report. Lancet HIV, 2023. 10(1): p. e42-e51 https://doi.org/10.1016/S2352-3018(22)00302-2
9. George, A.F., et al., Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART‑Suppressed Individuals. Front Immunol, 2022. 13: p. 803417 https://doi.org/10.3389/fimmu.2022.803417
10. Rallon, N., et al., A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection. J Med Virol, 2024. 96(5): p. e29646 https://doi.org/10.1002/jmv.29646
11. Rosas-Umbert, M., et al., Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers. J Virol, 2019. 93(4) https://doi.org/10.1128/JVI.01436-18
12. Alrubayyi, A., et al., Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction. Front Immunol, 2022. 13: p. 908697 https://doi.org/10.3389/fimmu.2022.908697
13. Saez-Cirion, A., et al., Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? Philos Trans R Soc Lond B Biol Sci, 2014. 369(1645): p. 20130436 https://doi.org/10.1098/rstb.2013.0436
14. Gomes, S.T.M., et al., Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil. BMC Infect Dis, 2017. 17(1): p. 381 https://doi.org/10.1186/s12879-017-2491-9
15. Pernas, M., et al., Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection. J Virol, 2018. 92(5) https://doi.org/10.1128/JVI.01805-17
16. Bansal, A., et al., Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts. AIDS, 2015. 29(17): p. 2245-54 https://doi.org/10.1097/QAD.0000000000000860
17. Vangelov, D., et al., T‑Lymphocyte Phenotypic and Mitochondrial Parameters as Markers of Incomplete Immune Restoration in People Living with HIV+ on Long-Term cART. Biomedicines, 2025. 13(8) https://doi.org/10.3390/biomedicines13081839
18. Hensley, K.S., et al., Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 Cohort. Open Forum Infect Dis, 2025. 12(7): p. ofaf336 https://doi.org/10.1093/ofid/ofaf336
19. Gebara, N.Y., V. El Kamari, and N. Rizk, HIV‑1 elite controllers: an immunovirological review and clinical perspectives. J Virus Erad, 2019. 5(3): p. 163-166 https://doi.org/10.1016/S2055-6640(20)30046-7
20. Jones, A.D., et al., HIV-1 controllers possess a unique CD8+ T cell activation phenotype and loss of control is associated with increased expression of exhaustion markers. PLoS One, 2025. 20(8): p. e0328706 https://doi.org/10.1371/journal.pone.0328706
21. Navas, A., et al., Circulating immune landscape and immune signatures in spontaneous HIV controllers. Front Immunol, 2025. 16: p. 1642482 https://doi.org/10.3389/fimmu.2025.1642482
22. Wu, R.C., P. Hwu, and L.G. Radvanyi, New insights on the role of CD8(+)CD57(+) T-cells in cancer. Oncoimmunology, 2012. 1(6): p. 954-956 https://doi.org/10.4161/onci.20307
23. Chew, G.M., et al., TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLoS Pathog, 2016. 12(1): p. e1005349 https://doi.org/10.1371/journal.ppat.1005349
24. Deguit, C.D.T., et al., Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T‑Cell Mitochondrial Features and ROS Content in HIV Infection. J Acquir Immune Defic Syndr, 2019. 82(2): p. 211-219 https://doi.org/10.1097/QAI.0000000000002121
25. Yu, F., et al., Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells From HIV-Infected Patients. J Acquir Immune Defic Syndr, 2017. 74(2): p. 206-212 https://doi.org/10.1097/QAI.0000000000001175
26. Angin, M., et al., Metabolic plasticity of HIV-specific CD8(+) T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat Metab, 2019. 1(7): p. 704-716 https://doi.org/10.1038/s42255-019-0081-4
27. Petrovas, C., et al., Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells. Blood, 2007. 109(6): p. 2505-13 https://doi.org/10.1182/blood-2006-05-021626
28. Gutierrez, A.D. and A. Balasubramanyam, Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine, 2012. 41(1): p. 1-10 https://doi.org/10.1007/s12020-011-9565-z
29. Schank, M., et al., The Impact of HIV‑ and ART‑Induced Mitochondrial Dysfunction in Cellular Senescence and Aging. Cells, 2021. 10(1) https://doi.org/10.3390/cells10010174
30. Lombardi, F., et al., Factors associated with oxidative stress in virologically suppressed people living with HIV on long-term antiretroviral therapy. AIDS Res Ther, 2024. 21(1): p. 100 https://doi.org/10.1186/s12981-024-00694-5
31. Sekine, T., et al., TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci Immunol, 2020. 5(49) https://doi.org/10.1126/sciimmunol.aba7918
32. Rutishauser, R.L., et al., TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. JCI Insight, 2021. 6(3) https://doi.org/10.1172/jci.insight.136648
33. Gabriel, S.S., et al., Transforming growth factor-beta-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. Immunity, 2021. 54(8): p. 1698-1714 e5 https://doi.org/10.1016/j.immuni.2021.06.007
34. Scharping, N.E., et al., The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity, 2016. 45(3): p. 701-703 https://doi.org/10.1016/j.immuni.2016.08.009
35. Siska, P.J., et al., Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight, 2017. 2(12) https://doi.org/10.1172/jci.insight.93411
36. Matarrese, P., et al., Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors. J Immunol, 2003. 170(12): p. 6006-15 https://doi.org/10.4049/jimmunol.170.12.6006
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Damian Vangelov, Radoslava Emilova, Yana Todorova, Svetla Blazheva, Ivailo Alexiev, Tsetsa Doichinova, Maria Nikolova (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
